Please login to the form below

EuBiologics

This page shows the latest EuBiologics news and features for those working in and with pharma, biotech and healthcare.

FDA approves first cholera vaccine in US

The WHO approved a third supplier of oral cholera vaccines - South Korea's EuBiologics - last December in a move designed to double production output to 6m doses a year.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Medical Strategic Director, Healthcare Advertising Agency: Salary TBC

Senior Medical Writer (Remote Working): Competitive Salary Offered

Director – Head of Public Affairs: Neg

Lead Medical Copywriter, Healthcare Brand Communications, London: Excellent package

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Account Director: Negotiable

Senior Account Manager - Med Comms: Highly Competitive Salary &Benefits

Account Director - Digital: Great salary and benefits

Scientific Team Lead: Competitive Salary

Healthcare PR Director: £100, 000 – £120, 000 benefits

Project / Account Manager (Medical Education): Salary TBC

SENIOR MEDICAL WRITER IN ONCOLOGY: Up to £60, 000.00 pension bonus

Account Manager, Healthcare Communications: £32, 000 - £40, 000 benefits

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Editorial Director – Medical Education: Neg

Account Manager- Manchester, Macclesfield or Glasgow: Negotiable

Associate Medical Director: Salary TBC

Director Healthcare PR Communications: Salary TBC

Healthcare Advertising Account Manager / Senior AM / AD: Salary TBC

Account Manager, Healthcare Advertising: Salary TBC

Scientific Director: Highly Competitive Salary &Benefits

Associate Medical Director: Highly Competitive

Experienced Editor, London, Medical Communications: Competitive package

Senior Account Manager / Account Director - Med Comms: Great salary and benefits

Subscribe to our email news alerts

PMHub

Add my company

BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?: Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Making Europe a leader in bioscience: boosting trust and opening minds: A vision of Paris as Europe’s leading hub for life sciences innovation...
Tackling a formidable foe: Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...